Evidence map›Paper›PMID 42557413›Full record

ArticleNature cell biology2026

BRD4 recruitment into HP1 condensates desilences transcription without erasure of repressive chromatin.

Christopher J Brandon, Sarah Robinson-Thiewes, Mangesh Kaulage, Wojciech Rosikiewicz, Matthew J Cuneo, Joseph Brett, Jindpreet Kandola, Walter H Lang, Jonathan Low, Ashraf Mohammed and 17 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature cell biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors.

Christopher J Brandon *Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN, USA.
Sarah Robinson-Thiewes *Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN, USA.
Mangesh Kaulage *Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN, USA.
Wojciech RosikiewiczCenter for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID http://orcid.org/0000-0001-7031-3430
Matthew J CuneoDepartment of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Joseph BrettDepartment of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Jindpreet KandolaDepartment of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN, USA.
Walter H LangDepartment of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN, USA.
Jonathan LowDepartment of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN, USA.
Ashraf MohammedDepartment of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN, USA.
Adithi DandaDepartment of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN, USA.
Sam RiderDepartment of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN, USA.
Marcus ValentineCytogenetics Shared Resource, St. Jude Children's Research Hospital, Memphis, TN, USA.
Jason OchoadaDepartment of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN, USA.
Brandon YoungDepartment of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID http://orcid.org/0000-0003-2973-2072
Theresa NguyenDepartment of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN, USA.
Sandra J KietlinskaDepartment of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN, USA.
Aaron B TaylorCell and Tissue Imaging Center, St. Jude Children's Research Hospital, Memphis, TN, USA.
Burkhard HoeckendorfCenter for Bioimage Informatics, St. Jude Children's Research Hospital, Memphis, TN, USA.
Patrick RodriguesThe Hartwell Center for Biotechnology, St. Jude Children's Research Hospital, Memphis, TN, USA.
Wenwei LinDepartment of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID http://orcid.org/0000-0001-8754-6150
Khaled KhairyCenter for Bioimage Informatics, St. Jude Children's Research Hospital, Memphis, TN, USA.
Beisi XuCenter for Applied Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID http://orcid.org/0000-0003-0099-858X
Anang A ShelatDepartment of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID http://orcid.org/0000-0002-6266-2910
Taosheng ChenDepartment of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID http://orcid.org/0000-0001-6420-3809
Tanja MittagDepartment of Structural Biology, St. Jude Children's Research Hospital, Memphis, TN, USA.ORCID http://orcid.org/0000-0002-1827-3811
Aseem Z AnsariDepartment of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN, USA. aseem.ansari@stjude.org.ORCID http://orcid.org/0000-0003-1432-4498

Funding

National Science Foundation (NSF) CEE-EFRI: #1933402U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) CA021765U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) GM154414U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) NS108376
6 · The paper itself

Abstract

How genes are desilenced without erasure of repressive chromatin is a poorly understood phenomenon. A dominant mode of repression occurs through methylation of lysine 9 of histone H3 (H3K9me3), a mark that engages heterochromatin protein 1 (HP1) to drive chromatin compaction and transcriptional silencing. The erasure and replacement of this repressive mark with acetyl/acyl groups recruits positive factors such as BRD4/BET to elicit gene transcription. Here we report that, in Friedreich's ataxia, a synthetic gene regulator (SynGR1/SynTEF1) licenses transcription across repressive chromatin without removal or replacement of H3K9me3 or HP1. By recruiting BRD4/BET into repressive GAA repeats in frataxin (FXN), SynGR1 creates a paradoxical state wherein gene transcription and repressive chromatin coexist. Contrary to convention, we find that BRD4 partitions into phase separated HP1 condensates in vitro and into HP1 puncta in patient-derived cells, thus offering a mechanistic explanation for desilencing transcription without the dispersal of mesoscale repressive chromatin. More broadly, our study highlights the dynamic nature of repressive chromatin and the context dependence of epigenetic marks in regulating gene expression.

Indexed as

ChromatinChromosomal Proteins, Non-HistoneFriedreich AtaxiaNuclear ProteinsTranscription FactorsTranscription, GeneticBromodomain Containing ProteinsCell Cycle ProteinsChromobox Protein Homolog 5HistonesHumansBRD4 protein, humanBromodomain Containing ProteinsCBX5 protein, humanCell Cycle ProteinsChromatinChromobox Protein Homolog 5Chromosomal Proteins, Non-HistoneHistonesNuclear ProteinsTranscription Factors

Identifiers

PMID42557413

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.